TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a TrialRohit Loomba, George Kemble, Katharine Grimmer et al.|Gastroenterology|2021Cited by 216
Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled studyStephen A. Harrison, M. Scott Harris, Jay Yang et al.|Journal of Hepatology|2024Cited by 135